Introduction of diabetic nephropathy

出自KMU Wiki

在2018年3月13日 (二) 16:50所做的修訂版本 (編輯) Guhjy (對話 | 貢獻) (新頁面: *The most common cause of ''incident ESRD'' and the 2nd commonest cause of ''prevalent ESRD'' in Taiwan *Prevalence **40% in type 1 and 2 DM **Because type 2 DM is much more common than t...) ←上一個		當前修訂版本 (2018年3月27日 (二) 12:43) (編輯) (撤銷) Guhjy (對話 | 貢獻)
(12個中途的修訂版本沒有顯示。)
第6行：		第6行：
	**DCCT (Diabetes Control and Complications Trial)		**DCCT (Diabetes Control and Complications Trial)
	***Type 1 DM		***Type 1 DM
-	***NEJM 1993;329:977: [[The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus|http://content.nejm.org/cgi/content/short/329/14/977]]	+	***[http://content.nejm.org/cgi/content/short/329/14/977| NEJM 1993;329:977. The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus]
	**UKPDS (UK Prospective Diabetes Study)		**UKPDS (UK Prospective Diabetes Study)
		+	*** [http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T1B-3TX4KPJ-3&_user=2411013&_rdoc=1&_fmt=&_orig=search&_sort=d&_docanchor=&view=c&_acct=C000051939&_version=1&_urlVersion=0&_userid=2411013&md5=6ce6fc1e30dcd65072e0b0bc72934dff| Lancet 1998;352:837. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)]
	***Type 2 DM		***Type 2 DM
-	***Lancet 1998;352:837: [[Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)|http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T1B-3TX4KPJ-3&_user=2411013&_rdoc=1&_fmt=&_orig=search&_sort=d&_docanchor=&view=c&_acct=C000051939&_version=1&_urlVersion=0&_userid=2411013&md5=6ce6fc1e30dcd65072e0b0bc72934dff]]	+	**Intensive glycemic control (HbA1C 6.5~7%) prevents microangiopathy in newly diagnosed DM, but effects on macroangiopathy (cardiovascular diseases and atherosclerosis) are less certain
-	**Effects on macroangiopathy (cardiovascular disease and atherosclerosis) are less certain	+

---

當前修訂版本

• The most common cause of incident ESRD and the 2nd commonest cause of prevalent ESRD in Taiwan
• Prevalence
  • 40% in type 1 and 2 DM
  • Because type 2 DM is much more common than type 1 DM, most diabetic nephropathy patients have type 2 DM
• Importance of hyperglycemia in DN
  • DCCT (Diabetes Control and Complications Trial)
    • Type 1 DM
    • NEJM 1993;329:977. The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus
  • UKPDS (UK Prospective Diabetes Study)
    • Lancet 1998;352:837. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
    • Type 2 DM
  • Intensive glycemic control (HbA1C 6.5~7%) prevents microangiopathy in newly diagnosed DM, but effects on macroangiopathy (cardiovascular diseases and atherosclerosis) are less certain